Consensus on molecular imaging and theranostics in neuroendocrine neoplasms
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Consensus on molecular imaging and theranostics in neuroendocrine neoplasms
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF CANCER
Volume 146, Issue -, Pages 56-73
Publisher
Elsevier BV
Online
2021-02-15
DOI
10.1016/j.ejca.2021.01.008
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tandem peptide receptor radionuclide therapy using 90Y/177Lu-DOTATATE for neuroendocrine tumors efficacy and side-effects - polish multicenter experience
- (2020) Jolanta Kunikowska et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2020) M. Pavel et al. ANNALS OF ONCOLOGY
- OpenDose: open access resources for nuclear medicine dosimetry
- (2020) Maxime Chauvin et al. JOURNAL OF NUCLEAR MEDICINE
- Targeted α-Emitter Therapy of Neuroendocrine Tumors
- (2020) Jolanta Kunikowska et al. SEMINARS IN NUCLEAR MEDICINE
- Treatment of inoperable or metastatic paragangliomas and pheochromocytomas with peptide receptor radionuclide therapy using 177Lu-DOTATATE
- (2019) Wouter Thomas Zandee et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- European Association of Nuclear Medicine Practice Guideline/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma
- (2019) David Taïeb et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- A Clinical Efficacy of PRRT in Patients with Advanced, Nonresectable, Paraganglioma-Pheochromocytoma, Related to SDHx Gene Mutation
- (2019) Kolasinska-Ćwikła et al. Journal of Clinical Medicine
- Favorable Outcome in Patients with Pheochromocytoma and Paraganglioma Treated with 177Lu-DOTATATE
- (2019) Achyut Ram Vyakaranam et al. Cancers
- EANM practice guideline for PET/CT imaging in medullary thyroid carcinoma
- (2019) Luca Giovanella et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Unmet needs in the international neuroendocrine tumor (NET) community: assessment of major gaps from the perspective of patients, patient advocates and NET healthcare professionals
- (2019) S. Leyden et al. INTERNATIONAL JOURNAL OF CANCER
- Pheochromocytoma and Paraganglioma
- (2019) Hartmut P.H. Neumann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2019) S Filetti et al. ANNALS OF ONCOLOGY
- PRRT neuroendocrine tumor response monitored using circulating transcript analysis: the NETest
- (2019) Lisa Bodei et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- 68Ga-somatostatin receptor analogs and 18F-FDG PET/CT in the localization of metastatic pheochromocytomas and paragangliomas with germline mutations: a meta-analysis
- (2018) Ying Kan et al. ACTA RADIOLOGICA
- Investigation of receptor radionuclide therapy with 177Lu-DOTATATE in patients with GEP-NEN and a high Ki-67 proliferation index
- (2018) Silvia Nicolini et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Guidelines on nuclear medicine imaging in neuroblastoma
- (2018) Zvi Bar-Sever et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- PRRT genomic signature in blood for prediction of 177Lu-octreotate efficacy
- (2018) Lisa Bodei et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Correlation of dose with toxicity and tumour response to 90Y- and 177Lu-PRRT provides the basis for optimization through individualized treatment planning
- (2018) Marta Cremonesi et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Prospective observational study of 177Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a dosimetry-guided study protocol on outcome and toxicity
- (2018) Ulrike Garske-Román et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Performance of68Ga-DOTA-Conjugated Somatostatin Receptor Targeting Peptide PET in Detection of Pheochromocytoma and Paraganglioma: A Systematic Review and Meta-Analysis
- (2018) Sangwon Han et al. JOURNAL OF NUCLEAR MEDICINE
- 68Ga PET Imaging in Patients With Neuroendocrine Tumors
- (2018) Simron Singh et al. CLINICAL NUCLEAR MEDICINE
- Comparison of glucagon-like peptide-1 receptor (GLP-1R) PET/CT, SPECT/CT and 3T MRI for the localisation of occult insulinomas: evaluation of diagnostic accuracy in a prospective crossover imaging study
- (2018) Kwadwo Antwi et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Peptide receptor radionuclide therapy (PRRT) in European Neuroendocrine Tumour Society (ENETS) grade 3 (G3) neuroendocrine neoplasia (NEN) - a single-institution retrospective analysis
- (2017) Sue Ping Thang et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F–DOPA
- (2017) Murat Fani Bozkurt et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Efficacy of Peptide Receptor Radionuclide Therapy for Functional Metastatic Paraganglioma and Pheochromocytoma
- (2017) Grace Kong et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Somatostatin Receptor Antagonists for Imaging and Therapy
- (2017) Melpomeni Fani et al. JOURNAL OF NUCLEAR MEDICINE
- 68 Ga-DOTATOC Imaging of Neuroendocrine Tumors: A Systematic Review and Metaanalysis
- (2017) Michael M. Graham et al. JOURNAL OF NUCLEAR MEDICINE
- The Impact of Somatostatin Receptor–Directed PET/CT on the Management of Patients with Neuroendocrine Tumor: A Systematic Review and Meta-Analysis
- (2017) Martin Barrio et al. JOURNAL OF NUCLEAR MEDICINE
- Safety, Biodistribution, and Radiation Dosimetry of68Ga-OPS202 in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase I Imaging Study
- (2017) Guillaume P. Nicolas et al. JOURNAL OF NUCLEAR MEDICINE
- Sensitivity Comparison of68Ga-OPS202 and68Ga-DOTATOC PET/CT in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase II Imaging Study
- (2017) Guillaume P. Nicolas et al. JOURNAL OF NUCLEAR MEDICINE
- Semantics in active surveillance for men with localized prostate cancer — results of a modified Delphi consensus procedure
- (2017) Sophie M. Bruinsma et al. Nature Reviews Urology
- ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine and Hybrid Imaging
- (2017) Anders Sundin et al. NEUROENDOCRINOLOGY
- ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Peptide Receptor Radionuclide Therapy with Radiolabelled Somatostatin Analogues
- (2017) Rodney J. Hicks et al. NEUROENDOCRINOLOGY
- Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
- (2017) Jonathan Strosberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Surgical Management of Small Bowel Neuroendocrine Tumors
- (2017) James R. Howe et al. PANCREAS
- Evaluation of somatostatin, CXCR4 chemokine and endothelin A receptor expression in a large set of paragangliomas
- (2017) Daniel Kaemmerer et al. Oncotarget
- Dual Somatostatin Receptor/FDG PET/CT Imaging in Metastatic Neuroendocrine Tumours: Proposal for a Novel Grading Scheme with Prognostic Significance
- (2017) David LH Chan et al. Theranostics
- Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
- (2017) Arvind Dasari et al. JAMA Oncology
- Long-term follow-up and role of FDG PET in advanced pancreatic neuroendocrine patients treated with 177Lu-D OTATATE
- (2016) Maddalena Sansovini et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- A principal component analysis is conducted for a case series quality appraisal checklist
- (2016) Bing Guo et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- 68Ga-DOTATATE Compared with 111In-DTPA-Octreotide and Conventional Imaging for Pulmonary and Gastroenteropancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis
- (2016) S. A. Deppen et al. JOURNAL OF NUCLEAR MEDICINE
- ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors
- (2016) M. Falconi et al. NEUROENDOCRINOLOGY
- ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas
- (2016) R. Garcia-Carbonero et al. NEUROENDOCRINOLOGY
- ENETS Consensus Guidelines Update for Neuroendocrine Neoplasms of the Jejunum and Ileum
- (2016) B. Niederle et al. NEUROENDOCRINOLOGY
- A Delphic consensus assessment: imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management
- (2016) Kjell Oberg et al. Endocrine Connections
- Renal function affects absorbed dose to the kidneys and haematological toxicity during 177Lu-DOTATATE treatment
- (2015) Johanna Svensson et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Increased SSTR2A and SSTR3 expression in succinate dehydrogenase–deficient pheochromocytomas and paragangliomas
- (2015) Marianne S. Elston et al. HUMAN PATHOLOGY
- Neoadjuvant Treatment of Nonfunctioning Pancreatic Neuroendocrine Tumors with [177Lu-DOTA0,Tyr3]Octreotate
- (2015) E. I. van Vliet et al. JOURNAL OF NUCLEAR MEDICINE
- Dose Response of Pancreatic Neuroendocrine Tumors Treated with Peptide Receptor Radionuclide Therapy Using 177Lu-DOTATATE
- (2015) E. Ilan et al. JOURNAL OF NUCLEAR MEDICINE
- The Impact of 68Ga-DOTATATE PET/CT Imaging on Management of Patients with Neuroendocrine Tumors: Experience from a National Referral Center in the United Kingdom
- (2015) E. Skoura et al. JOURNAL OF NUCLEAR MEDICINE
- Consensus on biomarkers for neuroendocrine tumour disease
- (2015) Kjell Oberg et al. LANCET ONCOLOGY
- Exploring the rising incidence of neuroendocrine tumors: A population-based analysis of epidemiology, metastatic presentation, and outcomes
- (2014) Julie Hallet et al. CANCER
- Chemotherapy with cyclophosphamide, vincristine and dacarbazine for malignant paraganglioma and pheochromocytoma: systematic review and meta-analysis
- (2014) N.D. Niemeijer et al. CLINICAL ENDOCRINOLOGY
- 68Ga-DOTATOC PET/CT provides accurate tumour extent in patients with extraadrenal paraganglioma compared to 123I-MIBG SPECT/CT
- (2014) Alexander Kroiss et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Favourable outcomes of 177Lu-octreotate peptide receptor chemoradionuclide therapy in patients with FDG-avid neuroendocrine tumours
- (2014) Raghava Kashyap et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors
- (2014) Lisa Bodei et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Using a Delphi Technique to Seek Consensus Regarding Definitions, Descriptions and Classification of Terms Related to Implicit and Explicit Forms of Motor Learning
- (2014) Melanie Kleynen et al. PLoS One
- Diagnostic role of Gallium-68 DOTATOC and Gallium-68 DOTATATE PET in patients with neuroendocrine tumors: a meta-analysis
- (2013) Jigang Yang et al. ACTA RADIOLOGICA
- Diagnostic Performance of Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography in Patients with Merkel Cell Carcinoma: A Systematic Review and Meta-Analysis
- (2013) Giorgio Treglia et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies
- (2013) Penny F. Whiting ANNALS OF INTERNAL MEDICINE
- 131I-MIBG therapy for malignant paraganglioma and phaeochromocytoma: systematic review and meta-analysis
- (2013) L. T. van Hulsteijn et al. CLINICAL ENDOCRINOLOGY
- Role of 18FDG PET/CT in patients treated with 177Lu-DOTATATE for advanced differentiated neuroendocrine tumours
- (2013) Stefano Severi et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Somatostatin receptor PET/CT in neuroendocrine tumours: update on systematic review and meta-analysis
- (2013) Håkan Geijer et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Normal biodistribution pattern and physiologic variants of 18F-DOPA PET imaging
- (2013) Sotirios Chondrogiannis et al. NUCLEAR MEDICINE COMMUNICATIONS
- Radionuclide Therapy in Neuroendocrine Tumours: A Systematic Review
- (2012) K.Y. Gulenchyn et al. CLINICAL ONCOLOGY
- Diagnostic performance of 18F-dihydroxyphenylalanine positron emission tomography in patients with paraganglioma: a meta-analysis
- (2012) Giorgio Treglia et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Cohort Study of Somatostatin-Based Radiopeptide Therapy With [90Y-DOTA]-TOC Versus [90Y-DOTA]-TOC Plus [177Lu-DOTA]-TOC in Neuroendocrine Cancers
- (2012) Linda Villard et al. JOURNAL OF CLINICAL ONCOLOGY
- 18F-FDG-PET and 18F-FDG-PET/CT in the detection of recurrent or metastatic medullary thyroid carcinoma: A systematic review and meta-analysis
- (2012) Xu Cheng et al. Journal of Medical Imaging and Radiation Oncology
- Individualized Dosimetry of Kidney and Bone Marrow in Patients Undergoing 177Lu-DOTA-Octreotate Treatment
- (2012) M. Sandstrom et al. JOURNAL OF NUCLEAR MEDICINE
- Consensus-based standards for best supportive care in clinical trials in advanced cancer
- (2012) S Yousuf Zafar et al. LANCET ONCOLOGY
- Clinical results of radionuclide therapy of neuroendocrine tumours with 90Y-DOTATATE and tandem 90Y/177Lu-DOTATATE: which is a better therapy option?
- (2011) Jolanta Kunikowska et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Glucagon-Like Peptide-1 Versus Somatostatin Receptor Targeting Reveals 2 Distinct Forms of Malignant Insulinomas
- (2011) D. Wild et al. JOURNAL OF NUCLEAR MEDICINE
- Evaluation of 177Lu-DOTA-sst2 Antagonist Versus 177Lu-DOTA-sst2 Agonist Binding in Human Cancers In Vitro
- (2011) R. Cescato et al. JOURNAL OF NUCLEAR MEDICINE
- Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
- (2011) Eric Raymond et al. NEW ENGLAND JOURNAL OF MEDICINE
- Everolimus for Advanced Pancreatic Neuroendocrine Tumors
- (2011) James C. Yao et al. NEW ENGLAND JOURNAL OF MEDICINE
- 18F-Fluorodeoxyglucose Positron Emission Tomography Predicts Survival of Patients with Neuroendocrine Tumors
- (2010) T. Binderup et al. CLINICAL CANCER RESEARCH
- 123I-Meta-Iodobenzylguanidine Scintigraphy for the Detection of Neuroblastoma and Pheochromocytoma: Results of a Meta-Analysis
- (2010) Arnold F. Jacobson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Role of 68Ga-DOTATATE PET in Patients with Neuroendocrine Tumors and Negative or Equivocal Findings on 111In-DTPA-Octreotide Scintigraphy
- (2010) R. Srirajaskanthan et al. JOURNAL OF NUCLEAR MEDICINE
- Immunohistochemical expression of somatostatin receptors in digestive endocrine tumours
- (2009) V. Zamora et al. DIGESTIVE AND LIVER DISEASE
- Somatostatin receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors
- (2009) Dik J Kwekkeboom et al. ENDOCRINE-RELATED CANCER
- Functional imaging of neuroendocrine tumors with combined PET/CT using68Ga-DOTATATE (DOTA-DPhe1,Tyr3-octreotate) and18F-FDG
- (2008) Irfan Kayani et al. CANCER
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Treatment With the Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate: Toxicity, Efficacy, and Survival
- (2008) Dik J. Kwekkeboom et al. JOURNAL OF CLINICAL ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started